← Back to Search

Epic 30-day unplanned readmission risk score for Unplanned Hospital Readmissions

N/A

Waitlist Available

Led By Donna Williams, MD

Research Sponsored by Wake Forest University Health Sciences

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up day 30

Awards & highlights

Study Summary

This trial assesses whether a computerized tool can help identify patients at high risk of unplanned readmission, so that they can receive care that may prevent readmission.

Eligible Conditions

Unplanned Hospital Readmissions
High-risk patients for unplanned readmission

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ day 30

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~day 30

This trial's timeline: 3 weeks for screening, Varies for treatment, and day 30 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of transitional and supportive care services (TSC) referrals by providers in the Control group

Number of transitional and supportive care services (TSC) referrals by providers in the Control group - Care Plus

Number of transitional and supportive care services (TSC) referrals by providers in the Control group - Faith Health

+12 more

Secondary outcome measures

30 day Readmission Rate

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: intervention group (IG)Experimental Treatment1 Intervention

The IG will consist of placing the Epic 30-day unplanned readmission risk score in the story board of providers - If a patient is identified as having a high risk of readmission defined as readmission risk >20%, a link to transitional and supportive care services (TSC) will be appear in the story board

Group II: control group (CG)Active Control1 Intervention

The CG will have the same transitional and supportive care services (TSC) orders available to them; however, they will not have the risk of readmission score present in their workflow

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Epic 30-day unplanned readmission risk score

2023

N/A

~70

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor

1,239 Previous Clinical Trials

1,004,115 Total Patients Enrolled

Donna Williams, MDPrincipal InvestigatorWake Forest University Health Sciences

Media Library

Epic 30-day unplanned readmission risk score Clinical Trial Eligibility Overview. Trial Name: NCT05413889 — N/A

Unplanned Hospital Readmissions Research Study Groups: intervention group (IG), control group (CG)

Unplanned Hospital Readmissions Clinical Trial 2023: Epic 30-day unplanned readmission risk score Highlights & Side Effects. Trial Name: NCT05413889 — N/A

Epic 30-day unplanned readmission risk score 2023 Treatment Timeline for Medical Study. Trial Name: NCT05413889 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any remaining slots available for individuals in this investigation?

"The clinical trial's information on clinicaltrials.gov indicates that this research is not currently soliciting participants, as the last update was made in October of 2022. However, there are other studies actively recruiting patients at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Validation and Implementation Design of an Epic Systems 30-day Unplanned Readmission Risk Model

2023. "Validation and Implementation Design of an Epic Systems 30-day Unplanned Readmission Risk Model". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05413889.